Sajjadi, Elham
Venetis, Konstantinos
Piciotti, Roberto
Gambini, Donatella
Blundo, Concetta
Runza, Letterio
Ferrero, Stefano
Guerini-Rocco, Elena
Fusco, Nicola
Article History
Received: 1 May 2021
Accepted: 19 October 2021
First Online: 28 October 2021
Declarations
:
: The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Institutional Review Board of Fondazione IRCCS Ca′ Granda – Ospedale Maggiore Policlinico (protocol code #620_2018bis). Informed written consent was obtained from all subjects involved in the study.
: Not applicable.
: E.G.R. has received advisory fees from Thermo Fisher Scientific and Novartis; honoraria from Thermo Fisher Scientific, Novartis, AstraZeneca, Roche; travel accommodation and expenses from Thermo Fisher Scientific, AstraZeneca, Roche, Novartis, Biocartis, Illumina. N.F. has received honoraria for consulting, advisory role, and/or speaker bureau from Merck Sharp & Dohme (MSD), Boehringer Ingelheim, and Novartis. These companies had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, and/or in the decision to publish the results. All other authors declare no potential conflicts of interest.